跳至主要内容
临床试验/NCT03096405
NCT03096405已完成不适用

Impact MRSA -PCR on Patient Management

Fondation Hôpital Saint-Joseph1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2014年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
50
试验地点
1
主要终点
Adaptation duration of antibiotherapy

研究概览

简要总结

Staphylococcus aureus represents one of the most met germs, with Escherichia coli, during bacteremia. Microbiologist distinguish at aureus S. two profiles of resistance in beta-lactamines: S. aureus sensitive to the methicillin ( SASM) and the S. aureus resistant to the methicillin ( SARM).

With the implementation of the MALDI-TOF, it is now possible to identify the origin responsible of the bacteremia the day of the positivity of the hemoculture ( J0) and to set up a treatment with adapted antibiotic, which, in the case of a sepsis to aureus S., is the vancomycine. Ye it was demonstrated, that the use of the vancomycine on the SASM increased the average duration of stay and a more important rate of relapse.

The PCR SARM was organized in the GHPSJ in 2014. It allows from the day of the positivity of the hemoculture ( J0), to determine the phenotype of resistance of S. aureus.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Hemoculture positive to Staphylococcus Aureus Methicillin Sensitive

排除标准

  • Positive test to Staphylococcus Aureus Methicillin Sensitive but not hospitalized.

结局指标

主要结局

Adaptation duration of antibiotherapy

时间窗: 24 hours

次要结局

  • average duration of hospitalization(day 30)
  • Mortality(Day 30)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验